Abstract
Fibroblast growth factor 2 (FGF-2) is a multi-functional protein involving in wound healing. However, FGF-2 is easily degradable in vivo, which limited its use for wound treatment. In this study, we investigated a drug-delivery model for FGF-2 via incorporation with biodegradable carboxylmethyl chitosan (CMCS). CMCS nanoparticles (NPs) could be synthesized by ionic gelation using CaCl2 as a crosslinking reagent with the CMCS:CaCl2 ratio of 1:0.8. Synthesized CMCS NPs had a diameter of 32.68 ± 6.83 nm, and were non-toxic at concentrations up to 2.5 mg/ml. Incorporated CMCS:FGF‐2 NPs had a diameter of 34.83 ± 5.89 nm and incorporation efficiency was 95%. CMCS:FGF‐2 NPs released 36.36% and 58.47% of FGF‐2 after 48 h incubation in two different pH of 7.4 and 5.8, respectively. The incorporation and release processes did not have a significant effect on FGF-2 activity. Simultaneously, CMCS:FGF-2 NPs could protect FGF‐2 from the degradation of trypsin in vitro. Our results laid the groundwork for the manufacturing of protein incorporated CMCS NPs for bio‐applications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
